Browse Items (1 total)

The results of a novel approach to the use of ketamine in refractory cancer pain are reported. In this prospective, multicenter, unblinded, open-label audit, 39 patients (with a total of 43 pains) received a short duration (3 to 5 days) ketamine…
Output Formats

atom, dcmes-xml, json, omeka-xml, rss2